Pharmaxis Ltd.

Pharmaxis Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.03
Market Cap
AUD96.61 M
Shares Outstanding
394.32 M
Public Float
320.43 M

Profile

Address
20 Rodborough Road
Sydney New South Wales (NSW) 2086
Australia
Employees -
Website http://www.pharmaxis.com.au
Updated 07/08/2019
Pharmaxis Ltd. operates as a specialty pharmaceutical company, which engages in the development and commercialization of therapeutic products for chronic respiratory disorders, autoimmune diseases, and improved lung function test. It operates through the following segments: Bronchitol and Aridol Business and New Drug Development. The Bronchitol and Aridol Business segment covers the ongoing clinical development, manufacture, and sale of the Bronchitol and Aridol globally.

Financials

View All

Kathleen M. Metters
Non-Executive Director
Kathleen M. Metters
Non-Executive Director